SCHEMBL3667635

SCHEMBL3667635

O=C(O)N1CCC(Nc2cccc(F)c2)C[C@@H]1CCCN(Cc1ccccc1)Cc1ccccc1.O=C(O)N1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ UBE2M P61081 2/20 0.39
▸ DCUN1D1 Q96GG9 2/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ DPP7 Q9UHL4 1/20 0.37
▸ FAAH O00519 1/20 0.36
▸ MLNR O43193 4/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ GFER P55789 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ SIGMAR1 Q99720 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4738420 0.90 ALDH1A1 (0.39) KMT2AALDH1A1POLBKDM4EUBE2M
SCHEMBL4786234 0.86 DPP7 (0.39) ALDH1A1UBE2MDCUN1D1DPP7FAAH
SCHEMBL3670283 0.83 SIGMAR1 (0.39) KMT2AALDH1A1POLBDPP7SIGMAR1
SCHEMBL3808885 0.83 DPP7 (0.41) ALDH1A1KDM4EDPP7
SCHEMBL4736472 0.80 ALDH1A1 (0.45) KMT2AALDH1A1KDM4ENPC1RAB9A
SCHEMBL4731396 0.78 KCNH2 (0.40) ALDH1A1CYP3A4KCNH2
SCHEMBL13079560 0.72 KDM4E (0.48) KMT2AALDH1A1POLBKDM4ENPC1
SCHEMBL3727160 0.71 RORC (0.38) ALDH1A1KCNH2
SCHEMBL4734750 0.71 DPP7 (0.37) KMT2AALDH1A1DPP7CYP3A4CYP2D6
SCHEMBL4131412 0.71 KDM4E (0.60) KMT2AALDH1A1POLBKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP claimed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO claimed
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback